Filing Details

Accession Number:
0001209191-15-052576
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-06-11 21:58:29
Reporting Period:
2015-06-09
Filing Date:
2015-06-11
Accepted Time:
2015-06-11 21:58:29
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1107421 Ziopharm Oncology Inc ZIOP Services-Specialty Outpatient Facilities, Nec (8093) 841475642
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1038704 Francois Lebel C/O Ziopharm Oncology, Inc., Navy Yard
One First Ave., Bldg #34
Boston MA 02129
Executive Vice President R&D No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-06-09 50,000 $4.34 50,000 No 4 M Direct
Common Stock Disposition 2015-06-09 50,000 $10.12 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2015-06-09 50,000 $0.00 50,000 $4.34
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
100,000 2023-12-30 No 4 M Direct
Footnotes
  1. The option is vested with respect to 50,000 shares; the option vests with respect to the remaining 100,000 shares on 12/31/2015 and 12/31/2016.